Crescent Biopharma Stock Price, News & Analysis
Company Description
Welcome to the overview page for Crescent Biopharma (cbio), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
Upcoming Events
TD Cowen investor presentation
Leerink investor presentation
CR-002 IND submission
CR-002 IND planned
CR-002 IND submission
CR-001 proof-of-concept data
CR-001 clinical data
Proof-of-concept data readout
ASCEND proof-of-concept data
Short Interest History
Short interest in Crescent Biopharma (cbio) currently stands at 794.6 thousand shares, up 0.1% from the previous reporting period, representing 6.9% of the float. Over the past 12 months, short interest has increased by 2244.6%. The 8.6 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Crescent Biopharma (cbio) currently stands at 8.6 days, up 246.2% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 762% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 11.6 days.
